Hemp changes don’t garner public attention the same way marijuana questions do, but ballot measures in a few key states could have a big impact on those markets. Voters in Colorado, the nation’s top-producing hemp state, will decide Nov. 6 whether to change the state constitution to make it easier to adjust hemp’s legal THC […]
Read More
Featured News
New Factbook
New Hemp & CBD Factbook
Curated by the researchers and editors of MJBizDaily, the Hemp & CBD Industry Digital Factbook contains data findings from exclusive industry surveys and analysis from available industry data reports about these rapidly evolving industries.
Purchase Now
More Exclusive Features
Academia joins CBD research boom, offering new market opportunities
Lack of significant research on the effect of cannabinoids has long been a bane to the CBD and hemp industries. But in the wake of the U.S. Drug Enforcement Administration’s decision to reschedule some cannabis-derived products, researchers are looking for ways to open and capitalize on new markets and uses. Two Stanford University researchers, Jonathan […]
Read More
When cannabis isn’t cannabis – and why hemp may suffer for it
How’s this for irony? The hemp industry’s rush to distance itself from marijuana has gone so far that hemp products can’t be sold in the world’s largest cannabis economy.
The development in California is a bitter lesson in being careful what you wish for.
Read More
Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels
As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for the Factbook described their stores are […]
Read More
Canada hemp changes could disrupt global CBD markets, but US producers hopeful
When Canada’s legal recreational marijuana market launches Wednesday, the nation will also allow its roughly 250 hemp farmers to sell flower for CBD extraction – a change that could have a global impact on CBD prices. “There are a lot of hemp producers who have been saving and drying their flowers for sale,” said Russ […]
Read More
Walmart Canada ‘fact-finding’ on potential for CBD product sales
The world’s largest retailer, Walmart, is considering selling CBD products in Canada, a development that comes just days before recreational marijuana markets open in the country. But Walmart says it isn’t ready to start selling cannabidiol just yet. “As we would for any new industry, Walmart Canada has done some preliminary fact-finding on this issue,” […]
Read More
3 business takeaways from the Heineken hemp trademark case
Hemp is a booming new industry, but some of the obstacles facing entrepreneurs are decidedly old. That’s the case for a startup hemp beer seeking trademark protection for its new brand, which is running headfirst into a global alcohol giant: Heineken. The dispute centers on a Pennsylvania company’s plans to release a hemp-infused beer, Tiger […]
Read More
How marijuana company executives can adapt to surging CBD sales
CBD and THC coexist in the cannabis plant. But can they coexist in the cannabis market? They can if they take a measured approach to the market.
Read More
Capitalizing on CBD: Seniors primed for nonintoxicating cannabis, but marketing needs to shift
Talking about CBD in a nursing home? You’d better bring extra chairs and slices of cake for the overflow crowd. Your audience will be all ears.
That was the case at one northern Colorado nursing home that offered a lecture about cannabis and Alzheimer’s.
Read More
What Farm Bill? Hemp industry shrugs off law’s expiration
The law that ushered in the modern hemp industry in the United States has expired, but hemp growers, processors and retailers are counting on legal assurances that the nation’s experiment in allowing limited hemp production won’t immediately end.
The 2014 Farm Bill, which authorized hemp production under state research programs, expired Sunday – the last day of the federal fiscal year.
Read More
DEA takes some CBD off Schedule 1 – with FDA approval
The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.
The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.
Read More